Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats (Q35522954)
Jump to navigation
Jump to search
scientific article published on 15 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats |
scientific article published on 15 July 2011 |
Statements
1 reference
Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats (English)
1 reference
Nanjoo Suh
1 reference
Bandaru S Reddy
1 reference
Andrew DeCastro
1 reference
Shiby Paul
1 reference
Hong Jin Lee
1 reference
Amanda K Smolarek
1 reference
Jae Young So
1 reference
Barbara Simi
1 reference
Chung Xiou Wang
1 reference
Naveena B Janakiram
1 reference
Vernon Steele
1 reference
Chinthalapally V Rao
1 reference
15 July 2011
1 reference
1 reference
4
1 reference
11
1 reference
1895-1902
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference